Atypical Parkinsonism with Pathological Dopamine Transporter Imaging in Neuronal Ceroid Lipofuscinosis Type 5
Open Access
- 15 September 2022
- journal article
- research article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 9 (8) , 1116-1119
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (FOR 2488 to N.B., WE 5919/2‐1 to A.W.)
This publication has 11 references indexed in Scilit:
- Autophagy–lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 diseaseScientific Reports, 2019
- Emerging new roles of the lysosome and neuronal ceroid lipofuscinosesMolecular Neurodegeneration, 2019
- Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)Brain, 2017
- Diagnosis and misdiagnosis of adult neuronal ceroid lipofuscinosis (Kufs disease)Neurology, 2016
- Adult-onset autosomal recessive ataxia associated with neuronal ceroid lipofuscinosis type 5 gene (CLN5) mutationsJournal of Neurology, 2014
- New nomenclature and classification scheme for the neuronal ceroid lipofuscinosesNeurology, 2012
- Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosisHuman Molecular Genetics, 2012
- Late Infantile Neuronal Ceroid Lipofuscinosis and Dopamine DeficiencyJournal of Child Neurology, 2011
- Neuronal ceroid lipofuscinosesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Autosomal dominant adult neuronal ceroid lipofuscinosis: Parkinsonism due to both striatal and nigral dysfunctionMovement Disorders, 2002